You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 62 No. 4, April 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Basic Science Seminars in Neurology
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (31)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Prion Diseases
 •Alert me on articles by topic

Human Prion Diseases

Molecular and Clinical Aspects

Markus Glatzel, MD; Katharina Stoeck, MD; Harald Seeger, MD; Thorsten Lührs, PhD; Adriano Aguzzi, MD, PhD

Arch Neurol. 2005;62:545-552.

Compared with that of other human pathogens, the proposed replicative cycle of prions is disarmingly simple. It encompasses misfolding of a single protein, the cellular prion protein (PrPC), into a disease-associated form called PrPSc. This is followed by PrPSc aggregation and possibly fragmentation of aggregates, which may augment the number of replicative units. Although there is no formal proof of the correctness of this model, a wealth of evidence indicates that pathogen-encoded informational nucleic acids are dispensable for prion replication. Despite the simplicity of the replicative process, the human phenotypic range of prion diseases is extremely variable and includes the sporadic, inherited, and acquired forms of Creutzfeldt-Jakob disease. In addition, prion diseases occur in a wide range of animals and can be propagated within and between animal species. The present review article discusses current concepts and controversies surrounding the basic biological features of prions.


Author Affiliations: Institute of Neuropathology and National Reference Center for Prion Diseases, University Hospital Zurich, Zurich, Switzerland (Drs Glatzel, Stoeck, Seeger, and Aguzzi); and The Salk Institute, Structural Biology Laboratory, La Jolla, Calif (Dr Lührs).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Physiology of the Prion Protein
Linden et al.
Physiol. Rev. 2008;88:673-728.
ABSTRACT | FULL TEXT  

Selective Incorporation of Polyanionic Molecules into Hamster Prions
Geoghegan et al.
J. Biol. Chem. 2007;282:36341-36353.
ABSTRACT | FULL TEXT  

Accumulation of Mutant Neuroserpin Precedes Development of Clinical Symptoms in Familial Encephalopathy with Neuroserpin Inclusion Bodies
Galliciotti et al.
Am. J. Pathol. 2007;170:1305-1313.
ABSTRACT | FULL TEXT  

Accelerated Accumulation of Misfolded Prion Protein and Spongiform Degeneration in a Drosophila Model of Gerstmann-Straussler-Scheinker Syndrome
Gavin et al.
J. Neurosci. 2006;26:12408-12414.
ABSTRACT | FULL TEXT  

Parkinsonism and dementia due to gliomatosis cerebri mimicking sporadic Creutzfeldt-Jakob disease (CJD)
Slee et al.
J. Neurol. Neurosurg. Psychiatry 2006;77:283-284.
FULL TEXT  

RNA-binding protein is involved in aggregation of light neurofilament protein and is implicated in the pathogenesis of motor neuron degeneration
Lin et al.
Hum Mol Genet 2005;14:3643-3659.
ABSTRACT | FULL TEXT  

Neuropathological investigation of dementia: a guide for neurologists
Love
J. Neurol. Neurosurg. Psychiatry 2005;76:v8-v14.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.